Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges
Cancer Treatment Reviews · 2023-03 · 114 · 102520
DOI: 10.1016/j.ctrv.2023.102520 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-03. Verfasst von Ying Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: yuying2…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Immunoconjugates. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China. Electronic address: yuying202103@163.com.
- Wenzhou Medical University, Wenzhou 325000, China. Electronic address: yehao_yang@163.com.
- Department of Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou 310022, China; Institute of Cancer Research and Basic Medical Sciences of Chinese…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Yu, Y., Yang, Y., Li, H., & Fan, Y. (2023). Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges. Cancer Treatment Reviews, 114, 102520. https://doi.org/10.1016/j.ctrv.2023.102520
Vancouver
Yu Y, Yang Y, Li H, Fan Y. Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges. Cancer Treatment Reviews. 2023;114:102520. doi:10.1016/j.ctrv.2023.102520
BibTeX
@article{Yu2023,
author = {Yu, Ying and Yang, Yehao and Li, Hui and Fan, Yun},
title = {Targeting HER2 alterations in non-small cell lung cancer: Therapeutic breakthrough and challenges},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {114},
pages = {102520},
doi = {10.1016/j.ctrv.2023.102520}
}
EUVIMED